Product
C3
1 clinical trial
1 indication
Indication
Pancreatic Cancer MetastaticClinical trial
Phase 2A Pilot Trial of Metformin, Digoxin, Simvastatin (C3) in Combination With Gemcitabine in Subjects With Recurrent / Refractory Metastatic Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-12-01